---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-018125"
form_type: "8-K"
ticker: "HRMY"
cik: "0001802665"
company_name: "Harmony Biosciences Holdings, Inc."
filed_at: "2023-11-08T23:59:59+00:00"
generated_at: "2026-06-08T10:12:01.005230+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Harmony Biosciences appoints Peter Anastasiou to Board of Directors

## Summary
- Appointed as Class III director effective November 5, 2023; term expires at 2026 annual meeting.
- Board expanded from nine to ten members; Anastasiou deemed independent.
- Anastasiou is CEO of Capsida Biotherapeutics and former President of North America at Lundbeck.
- Will serve on Compensation Committee; brings CNS and business development expertise.

## SEC filing metadata
- accession: 0001558370-23-018125
- form_type: 8-K
- ticker: HRMY
- cik: 0001802665
- company_name: Harmony Biosciences Holdings, Inc.
- filed_at: 2023-11-08T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1802665/000155837023018125/0001558370-23-018125-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1802665/000155837023018125/hrmy-20231105x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-018125
- JSON: https://secwatch.observer/filing/0001558370-23-018125.json
- Plain text: https://secwatch.observer/filing/0001558370-23-018125.txt

## Key facts
- Executive change
  Peter Anastasiou was appointed as Class III director at Harmony Biosciences Holdings, Inc..
  - Action: appointed
  - Role: Class III director
  source text: appointed Peter Anastasiou as a Class III director of the Company with an initial term expiring at the Company’s 2026 annual meeting of stockholders, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1802665/000155837023018125/0001558370-23-018125-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.